Zalutsky MR - Search Results

1

Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.

Reardon DA, Zalutsky MR, Bigner DD. Reardon DA, et al. Among authors: zalutsky mr. Expert Rev Anticancer Ther. 2007 May;7(5):675-87. doi: 10.1586/14737140.7.5.675. Expert Rev Anticancer Ther. 2007. PMID: 17492931 Review.

2

Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates.

Moseley RP, Papanastassiou V, Zalutsky MR, Ashpole RD, Evans S, Bigner DD, Kemshead JT. Moseley RP, et al. Among authors: zalutsky mr. Int J Cancer. 1992 Aug 19;52(1):38-43. doi: 10.1002/ijc.2910520109. Int J Cancer. 1992. PMID: 1500225

3

Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model.

Garg PK, Garg S, Bigner DD, Zalutsky MR. Garg PK, et al. Among authors: zalutsky mr. Cancer Res. 1992 Sep 15;52(18):5054-60. Cancer Res. 1992. PMID: 1516061

4

Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.

Vaidyanathan G, Bigner DD, Zalutsky MR. Vaidyanathan G, et al. Among authors: zalutsky mr. J Nucl Med. 1992 Aug;33(8):1535-41. J Nucl Med. 1992. PMID: 1634947 Free article.

5

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD. Humphrey PA, et al. Among authors: zalutsky mr. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4207-11. doi: 10.1073/pnas.87.11.4207. Proc Natl Acad Sci U S A. 1990. PMID: 1693434 Free PMC article.

6

Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.

Schuster JM, Garg PK, Bigner DD, Zalutsky MR. Schuster JM, et al. Among authors: zalutsky mr. Cancer Res. 1991 Aug 15;51(16):4164-9. Cancer Res. 1991. PMID: 1714341

7

Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.

Zalutsky MR, Moseley RP, Benjamin JC, Colapinto EV, Fuller GN, Coakham HP, Bigner DD. Zalutsky MR, et al. Cancer Res. 1990 Jul 1;50(13):4105-10. Cancer Res. 1990. PMID: 2162252

8

Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.

Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Cope DA, et al. Among authors: zalutsky mr. Cancer Res. 1990 Mar 15;50(6):1803-9. Cancer Res. 1990. PMID: 2407344

9

Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.

Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD. Colapinto EV, et al. Among authors: zalutsky mr. Cancer Res. 1990 Mar 15;50(6):1822-7. Cancer Res. 1990. PMID: 2407345

10

Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.

Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD. Lee YS, et al. Among authors: zalutsky mr. Cancer Res. 1988 Feb 1;48(3):559-66. Cancer Res. 1988. PMID: 2446747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters